Who We Are

The Philosophy of Open Therapeutics

therapoid

Enjoy our one-page summary

Open Therapeutics™ facilitates interdisciplinary open science developments by enabling capable, responsible, and socioeconomically diverse researchers and students around the world to collaborate.

Open Therapeutics has two components: the free Therapoid platform platform for open scientific collaboration, and (ii) open technologies available for rapid prototyping.

Open Therapeutics enables open access, open collaboration, rapid prototyping, meritocracy, and community. The goal is to lower costs, reduce risks and time, and broaden markets for therapeutics specifically and science in general.

All the sciences impact animal, human, and global health outcomes. This includes the impacts brought about by climate change. Our interdisciplinary approach supports achieving positive health outcomes for everyone.

Therapoid enables scientists and students to share research easily, while it also opens a path to develop untapped technologies. Simple to use tools enable more effective collaboration.

Therapoid integrates open technologies, grant funding, manuscript development prepeer review, preprint server, open access, open data, artificial intelligence, and blockchain-based cryptocurrency into a unified collaborative ecosystem.

A significant development, and a first for open science, collaborating researchers and students are awarded ScienceCoins cryptocurrency for sharing and furthering science.

By registering to use the Therapoid platform, you explicitly agree to accept a Creative Commons-like user agreement. As part of the registration, we ask you to agree explicitly to use open licenses for the development of any relevant technologies and knowledge available, or made available, in Therapoid.

Therapoid™ is currently released as an “alpha” test version. During this phase, we invite only select users, researchers, and innovators to help develop the core framework. We expect to launch the beta version to a wider user group in January 2017.

If you are interested in becoming a platform tester, please contact us.

Our Story

“Science and Collaboration should have no borders.”

Founded in 2009, Open Therapeutics was a global life sciences tech company based upon synthetic biology. After developing and attracting a wide array of synthetic biology-based technologies, Open Therapeutics pivoted from being a lab bench-based company into an open science organization to make research freely available to all researchers.

Our Mission

We believe strongly that scientific collaboration free of constraints is paramount to promoting diversity in research and reducing the cost of healthcare.

At Open Therapeutics, we pride ourselves on a core set of values that are aligned with our mission. These principles are the foundation that drives our everyday activities.

We are not anti- patents, copyrights, and trade secrets. Rather, we believe there is a parallel opportunity to those "protections".